Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Walid Rasheed"'
Autor:
Ahmed Kotb Abdrabou, Fahad Al Sharif, Riad El Fakih, Hazaa Al Zahrani, Ruah Al Yamany, Mostafa Saleh, Saud Alhayli, Zakia Al Somali, Ahmad Alotaibi, AlFadel AlShaibani, Farah Deeba, Maryam Asif, Syed Ahmed Osman Ali Ahmed, Feras Al Fraih, Marwan Shaheen, Ali Alahmari, Walid Rasheed, Naeem Arshad Chaudhri, Fahad Al Mohareb, Mahmoud Aljurf, Amr Hanbali
Publikováno v:
Annals of Saudi Medicine, Vol 44, Iss 2, Pp 93-103 (2024)
BACKGROUND: Multiple myeloma (MM) represents the second most common hematologic malignancy (15%). Induction with bortezomib, cyclophosphamide, and dexamthasone VCd (d: low dose dexamthasone) regimen is widely used due to its high effectiveness, low t
Externí odkaz:
https://doaj.org/article/d66c5872efd243c381a2b8bbe39d109d
Autor:
Alfadil Haroon, Syed Osman Ahmed Ahmed, Hazzaa Alzahrani, Riad El Fakih, Ali Alahmari, Alfadel Alshaibani, Naeem Chaudhri, Fahad Almohareb, Saud Alhayli, Marwan Shaheen, Abdulwahab Albabtain, Fahad Alsharif, Feras Alfraih, Walid Rasheed, Mahmoud Aljurf
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S19-S20 (2023)
Objective Background: Aplastic anemia is pancytopenia with a hypocellular bone marrow [
Externí odkaz:
https://doaj.org/article/b7ebc9153dc04124ab792ca949de7f81
Autor:
Samar Alfaqawi, Mostafa Mohammed Saleh, Ahmed Kotb, Ghada Abdallah, Leena Ali, Reem Alasbali, Taimor Hussain, Haroon Alfadhil, Ahmed Bin Salman, Momen Nassani, Yazeed Baujaifer, Mohammed I. Sharif, Marwa Nassar, Sarah Samarkandi, Heba Madien, Amal Hejab, Ruah Alyamany, Ahmed Alnughmush, Abdullah Alamer, Ayman Saad, Mansour Alfayez, Abdelwahab Albabtain, Alfadel Alshaibani, Ahmad Alotaibi, Saud Alhayli, Marwan Shaheen, Syed O. Ahmed, Riad Elfakih, Amr Hanbali, Feras Alfraih, Walid Rasheed, Fahad Alsharif, Naeem Chaudhri, Hazza Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Ali Alahmari
Publikováno v:
HemaSphere, Vol 7, p e06488d6 (2023)
Externí odkaz:
https://doaj.org/article/a0b321b6475b4ca8b1e7c3944e1ad24a
Autor:
Ahmed Kotb Abdrabou, Fahad Al Sharif, Riad El Fakih, Shahrukh Hashmi, Yasser Mohamed Khafaga, Saud Alhayli, Hazaa Al Zahrani, Syed Ahmed, Feras Al Fraih, Marwan Shaheen, Walid Rasheed, Naeem Arshad Chaudhri, Fahad Al Mohareb, Hala Khalil, Mahmoud Aljurf, Amr Hanbali
Publikováno v:
Annals of Saudi Medicine, Vol 41, Iss 4, Pp 198-205 (2021)
BACKGROUND: In 2015, multiple myeloma (MM) represented 1% of all cancers and about 5% of hematologic malignancies in Saudi cancer registry. We conducted this large study because only small pilot studies have examined MM outcomes after autologous stem
Externí odkaz:
https://doaj.org/article/6fca6d84c8424d37a6aa1913a7a1936d
Autor:
Mona Hassanein, Riad El Fakih, Walid Rasheed, Syed Ahmed, Marwan Shaheen, Naeem Chaudhri, Fahad Alsharif, Shad Ahmed, Amr Hanbali, Alfadel AlShaibani, Feras Alfraih, Saud Alhayli, Tusneem Elhassan, Ali Alahmari, Hazzaa Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Shahrukh Hashmi
Publikováno v:
eJHaem, Vol 2, Iss 2, Pp 249-256 (2021)
Abstract Secondary acute myeloid leukemia (sAML) includes AML as a complication of an antecedent hematological disorder or a therapy‐related AML. Large registry‐based data identified sAML as an independent poor‐outcome type of AML post allogene
Externí odkaz:
https://doaj.org/article/c864142de1904dff964406052a91be60
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S48- (2021)
Objective: To study the outcomes of allo-HCT in patients with hematological malignancy who received BU3 (9.6 mg/kg) based conditioning from matched related or unrelated donors. Methodology: A retrospective analysis of KFSHRC- BMT Database, we identif
Externí odkaz:
https://doaj.org/article/990786919fe843c4b5cddd2870568c6b
Autor:
Amr Hanbali, Ahmed Kotb, Riad El Fakih, Feras Alfraih, Syed Osman Ahmed, Marwan Shaheen, Saud Alhayli, Ali Alahmari, Ahmad Alotaibi, Alfadel Alshaibani, Mahmoud Abu Riash, Farah Deeba, Maryam Asif, Walid Rasheed, Hazzaa Alzahrani, Fahad Alsharif, Naeem Chaudhri, Fahad Almohareb, Mahmoud Aljurf
Publikováno v:
Leukemia Research Reports, Vol 16, Iss , Pp 100270- (2021)
Background: Treating adolescents and young adults (AYA) patients with acute lymphoblastic leukemia (ALL) using pediatric-inspired protocols have shown improvement in outcomes. Most data available in the literature of such protocols is derived from we
Externí odkaz:
https://doaj.org/article/0920ff50755a4213b57bcd981e064517
Publikováno v:
Advances in Hematology, Vol 2017 (2017)
Multiple myeloma (MM) is a heterogeneous hematologic malignancy involving the proliferation of plasma cells derived by different genetic events contributing to the development, progression, and prognosis of this disease. Despite improvement in treatm
Externí odkaz:
https://doaj.org/article/886ba6bf5e8b4f82b7f63ff803545bc2
Publikováno v:
Cells, Vol 7, Iss 1, p 4 (2018)
The FMS-like tyrosine kinase 3 (FLT3) pathway has an important role in cellular proliferation, survival, and differentiation. Acute myeloid leukemia (AML) patients with mutated FLT3 have a large disease burden at presentation and a dismal prognosis.
Externí odkaz:
https://doaj.org/article/e528d20dd5cc4833b7014c6895089ace
Autor:
Ibrahim N Muhsen, Sebastian Galeano, Dietger Niederwieser, Mickey B C Koh, Per Ljungman, Clarisse M Machado, Mohamed A Kharfan-Dabaja, Rafael de la Camara, Yoshihisa Kodera, Jeff Szer, Walid Rasheed, Simone Cesaro, Shahrukh K Hashmi, Adriana Seber, Yoshiko Atsuta, Mostafa F Mohammed Saleh, Alok Srivastava, Jan Styczynski, Abdulrahman Alrajhi, Reem Almaghrabi, Muhammad Bilal Abid, Roy F Chemaly, Usama Gergis, Eolia Brissot, Riad El Fakih, Marcie Riches, Malgorzata Mikulska, Nina Worel, Daniel Weisdorf, Hildegard Greinix, Catherine Cordonnier, Mahmoud Aljurf
Publikováno v:
The Lancet Haematology. 10:e295-e305